Differential Thrombogenesis by EPA and DHA Mediated by HDL

Clinical trial NCT06494488 · RECRUITING

Trial details

NCT number: NCT06494488
Sponsor: The Miriam Hospital
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Lipid Metabolism Disorders Hypertriglyceridemia

Start date: 2025-07-10
Primary completion: 2027-08-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.